Outcome
    Moderate Evidence

    Betaine (TMG) for Homocysteine Reduction

    Betaine lowers homocysteine independently of folate, especially post-methionine load.

    Overview

    Betaine, also sold as trimethylglycine, has one of the most clearly established biochemical effects of any supplement: it lowers plasma homocysteine. This is not a contested claim - it is accepted pharmacology, and betaine is an approved prescription treatment for inherited homocystinuria.
    Homocysteine is an amino acid intermediate that accumulates when methylation pathways are under-supplied. Elevated levels are associated in observational data with cardiovascular and cognitive risk, which is why lowering it has been an attractive target. The uncomfortable part is what happened when that target was tested. Large trials lowering homocysteine with B vitamins reduced the marker reliably but did not reduce cardiovascular events, which suggests homocysteine may be a marker of risk rather than a cause of it.

    No studies are currently linked to this pairing

    This page reflects established biochemistry and conventional dosing rather than trial data attached to this outcome in our library.

    How It Works

    Homocysteine has two disposal routes. It can be remethylated back to methionine, or irreversibly transsulfurated to cysteine using vitamin B6. Betaine drives the first route.
    Betaine-homocysteine methyltransferase transfers a methyl group from betaine to homocysteine, regenerating methionine. Critically, this pathway is independent of folate and vitamin B12, which power the alternative remethylation route - so betaine offers a parallel road when the folate route is limited by deficiency or by genetic variation such as MTHFR polymorphisms. Betaine's other role, as an organic osmolyte protecting cells against osmotic and dehydration stress, is what underlies its separate reputation in exercise contexts and is unrelated to homocysteine.

    Dosing & Protocol

    Doses for homocysteine lowering are considerably higher than the amounts found in food or in exercise-focused products.
    ContextDoseFormTiming
    Homocysteine lowering3-6 g dailyBetaine anhydrous (TMG)Split into two doses with food
    Exercise and osmolyte use2.5 g dailyBetaine anhydrousAny time; not a homocysteine dose
    Dietary sources0.5-2 g daily typical intakeBeets, spinach, wheat bran, quinoa-
    Assessment pointRecheck at 8-12 weeksFasting plasma homocysteineAlongside B12 and folate status

    Check B12 and folate first

    Elevated homocysteine is most often a B12 or folate deficiency signal. Correcting the deficiency addresses the cause; betaine bypasses it.

    Evidence

    There are currently no studies linked to this pairing in our library, so no study list is shown.
    The homocysteine-lowering effect itself is well documented across dose-response trials in healthy adults and in patients with elevated levels, and betaine's licensed use in homocystinuria reflects regulatory acceptance of that effect. What is not established is downstream benefit. Homocysteine-lowering trials using B vitamins failed to reduce cardiovascular events, and no trial has shown that betaine-driven lowering improves clinical outcomes. There is also a documented trade-off: betaine raises LDL cholesterol and total cholesterol in several trials, which works against cardiovascular intent.

    Lowering the number may not help

    Marker reduction is reliable; clinical benefit is not demonstrated. Betaine also raises LDL, which complicates the cardiovascular case.

    Safety

    Betaine is generally well tolerated. Gastrointestinal upset, nausea and a distinctive fishy body odour from trimethylamine production are the usual complaints at higher doses.

    Monitor your lipids

    Betaine has repeatedly been shown to raise LDL and total cholesterol at homocysteine-lowering doses. Check a lipid panel before and during use.

    Anyone with existing dyslipidaemia or established cardiovascular disease should discuss betaine with their clinician before starting, given the LDL effect. Safety in pregnancy and breastfeeding at supplemental doses is not established, and kidney impairment warrants medical advice given altered clearance.

    Interactions & Conflicts

    Betaine has few drug interactions; the meaningful conflicts are nutritional and lipid-related.
    Interacts withSeverityMechanismAction
    Lipid-lowering therapy
    moderate
    Betaine raises LDL, working against treatmentMonitor lipids and discuss with your prescriber
    Untreated B12 deficiency
    moderate
    Normalising homocysteine can mask an unresolved deficiencyTest and correct B12 before using betaine
    Choline supplements
    low
    Choline is a betaine precursor; additive trimethylamine productionExpect stronger body odour effects
    Methotrexate
    low
    Both act on one-carbon metabolismMention to your prescriber

    References

    No studies are currently linked to this pairing, so no reference list is available. This section will populate as evidence is added to the library.

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.